• Subcutaneous Tanezumab for Osteoarthritis: Is the Early Improvement in Pain and Function Meaningful and Sustained? 

      Berenbaum, Francis; Langford, R.; Perrot, S.; Miki, Kenji; Blanco García, Francisco J; Yamabe, Takaharu; Isogawa, N.; Junor, Rod; Carey, William; Viktrup, Lars; West, Christine R.; Brown, Mark T.; Verburg, Kenneth M. (Wiley, 2021-03-16)
      [Abstract] Background: To evaluate if early improvements in pain and function with subcuta-neous tanezumab are meaningful and sustained over 24 weeks. Methods: Patients with moderate- to- severe osteoarthritis (hip or ...